. Author manuscript; available in PMC: 2014 Aug 24.

Published in final edited form as: Plast Reconstr Surg. 2012 Sep;130(3):495–502. doi: 10.1097/PRS.0b013e31825dbefe

Table 2.

Surgical Site Infection, by Type of Reconstruction

	Pre-SCIP (%)	SCIP (%)	p^*
No. of patients	116	134
Total patients with SSI	21 (18.1)	46 (34.3)	0.004
SSI treated with oral antibiotics	10 (8.6)	15 (11.2)	0.499
SSI treated with IV antibiotics	6 (5.2)	9 (6.7)	0.608
SSI requiring reoperation	5 (4.3)	22 (16.4)	0.002
Reconstruction with tissue expander	92 (79.3)	99 (73.9)	0.313
Infected tissue expander	17 (18.5)	34 (34.3)	0.013
Infected tissue expander requiring reoperation	5 (5.4)	18 (18.2)	0.007
Reconstruction with autologous flap	24 (20.7)	35 (26.1)	0.313
Infected autologous flap	4 (16.7)	12 (34.3)	0.135
Infected autologous flap requiring reoperation	0 (0)	4 (11.4)	0.115

SCIP, Surgical Care Improvement Project; SSI, surgical-site infection; IV, intravenous.

Italicized values represent significant findings.